Apex, NC, United States of America

Ken Bolam

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ken Bolam - Innovator in Therapeutic Treatment Solutions

Introduction

Ken Bolam is a notable inventor based in Apex, NC (US). He has made significant contributions to the field of therapeutic treatment through his innovative designs. His work focuses on enhancing patient care and comfort during treatment procedures.

Latest Patents

Ken Bolam holds a patent for a therapeutic treatment table. This invention comprises a frame and a treatment platform that is mounted on the frame, designed to support at least a portion of the body of a patient. A preferred version of the treatment table includes an arm support section that is mounted on the frame. This arm support section features a moveable arm support that allows patients to adjust their position independently of the treatment platform. Ken Bolam's patent is a testament to his commitment to improving therapeutic practices.

Career Highlights

Ken Bolam is associated with Encore Medical Asset Corporation, where he applies his expertise in medical device innovation. His work at the company has been instrumental in developing solutions that enhance patient treatment experiences. With a focus on practical applications, he has successfully brought his ideas to fruition.

Collaborations

Ken has collaborated with talented individuals such as Greg Day and Jeff Powe. These partnerships have fostered a creative environment that encourages innovation and the development of new therapeutic solutions.

Conclusion

Ken Bolam's contributions to the field of therapeutic treatment are noteworthy. His innovative therapeutic treatment table exemplifies his dedication to improving patient care. Through his work and collaborations, he continues to make a positive impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…